Medicare Enrolled
Dr. Tamer Yacoub, M.D.
Endocrinology · Fall River, MA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Yacoub from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yacoub?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Yacoub
Dr. Tamer Yacoub is an endocrinology specialist in Fall River, MA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Yacoub performed 8,947 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Yacoub received a total of $741,340 from 59 pharmaceutical and/or device companies across 1412 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Yacoub is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 5% volume in MA
$741,340 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗8,947
Medicare services
Top 5% in MA for endocrinology
Not available
Unique patients (not deduplicated)
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
878 | $93 | $370 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
784 | $8 | $17 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
559 | $10 | $40 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
547 | $13 | $50 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
489 | $3 | $10 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
481 | $5 | $18 |
| Liver enzyme (SGOT) level test A blood test that measures the level of the liver enzyme SGOT to help assess liver health. |
481 | $5 | $18 |
| Liver enzyme (SGPT) level test A blood test that measures the level of the liver enzyme SGPT to assess liver function. |
476 | $5 | $18 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
465 | $16 | $58 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
457 | $6 | $30 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
457 | $5 | $30 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
384 | $62 | $230 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
368 | $9 | $31 |
| Blood potassium level test A blood test that measures the amount of potassium in your body. Potassium is an electrolyte that helps control heart and muscle function. |
352 | $5 | $16 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
218 | $39 | $162 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
214 | $27 | $113 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
204 | $41 | $206 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
190 | $40 | $125 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
130 | $29 | $99 |
| Total calcium level test A blood test that measures the total amount of calcium in your body. |
101 | $5 | $18 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
94 | $136 | $638 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
83 | $31 | $120 |
| Albumin level test A blood test that measures the amount of albumin, a protein made by the liver, in your body. |
76 | $5 | $17 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
68 | $56 | $250 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
67 | $10 | $36 |
| Parathyroid hormone level test A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones. |
57 | $40 | $138 |
| Direct bilirubin level test A blood test that measures the amount of direct bilirubin in your body. Direct bilirubin is the form of the waste product processed by the liver. |
56 | $5 | $17 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
55 | $140 | $470 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
39 | $8 | $29 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
32 | $96 | $350 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $122 | $522 |
| Continuous glucose monitoring, tissue fluid This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin. |
17 | $45 | $180 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
15 | $4 | $14 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
15 | $104 | $370 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
12 | $8 | $26 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$741,340
Total received (2018-2024)
Avg $105,906/year across 7 years
Top 0% in MA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
1,412
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$99,744
2023
$113,676
2022
$171,792
2021
$53,988
2020
$45,011
2019
$118,223
2018
$138,906
Payments by company (2024)
Lilly USA, LLC
$51,170
Novo Nordisk Inc
$24,632
Bayer Healthcare Pharmaceuticals Inc.
$13,883
Boehringer Ingelheim Pharmaceuticals, Inc.
$4,051
Ascensia Diabetes Care Us Inc.
$4,017
Amgen Inc.
$590
Corcept Therapeutics
$331
Esperion Therapeutics, Inc.
$172
Xeris Pharmaceuticals, Inc.
$111
Mannkind Corporation
$90
Abbott Laboratories
$85
Alexion Pharmaceuticals, Inc.
$76
Novartis Pharmaceuticals Corporation
$63
AstraZeneca Pharmaceuticals LP
$59
Lexicon Pharmaceuticals, Inc.
$58
SANOFI-AVENTIS U.S. LLC
$50
PFIZER INC.
$46
Amneal Pharmaceuticals LLC
$44
Radius Health, Inc.
$40
ABBVIE INC.
$34
Currax Pharmaceuticals LLC
$31
Tandem Diabetes Care, Inc.
$29
Kyowa Kirin, Inc.
$24
Dexcom, Inc.
$20
Chiesi USA, Inc.
$19
Lucid Diagnostics Inc.
$17
Top 3 companies account for 89.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$290,773
Lilly USA, LLC
$167,641
Corcept Therapeutics
$54,295
Boehringer Ingelheim Pharmaceuticals, Inc.
$34,689
Amryt Pharma Holdings Ltd
$27,265
Bayer Healthcare Pharmaceuticals Inc.
$22,758
Aegerion Pharmaceuticals, Inc.
$19,161
AbbVie, Inc.
$19,146
SANOFI-AVENTIS U.S. LLC
$17,900
Merck Sharp & Dohme Corporation
$16,654
Esperion Therapeutics, Inc.
$16,403
Janssen Pharmaceuticals, Inc
$14,875
Xeris Pharmaceuticals, Inc.
$7,997
Amgen Inc.
$7,263
Bayer HealthCare Pharmaceuticals Inc.
$6,126
AbbVie Inc.
$5,562
Ascensia Diabetes Care Us Inc.
$4,017
Eli Lilly and Company
$2,250
AstraZeneca Pharmaceuticals LP
$1,527
Abbott Laboratories
$843
Amarin Pharma Inc.
$768
Zealand Pharma US, Inc.
$750
MannKind Corporation
$318
Mannkind Corporation
$160
Alexion Pharmaceuticals, Inc.
$160
Merck Sharp & Dohme LLC
$150
Dexcom, Inc.
$137
Tandem Diabetes Care, Inc.
$135
Novartis Pharmaceuticals Corporation
$122
Inari Medical, Inc.
$101
Kyowa Kirin, Inc.
$99
ABBVIE INC.
$91
Shire North American Group Inc
$89
Antares Pharma, Inc.
$86
Lexicon Pharmaceuticals, Inc.
$85
GlaxoSmithKline, LLC.
$83
Regeneron Healthcare Solutions, Inc.
$75
Insulet Corporation
$70
Radius Health, Inc.
$64
Amneal Pharmaceuticals LLC
$60
Medtronic, Inc.
$58
LifeScan, Inc.
$56
CeQur Corporation
$54
Ipsen Biopharmaceuticals, Inc
$50
PFIZER INC.
$46
Kowa Pharmaceuticals America, Inc.
$44
Nevro Corp.
$32
IBSA Pharma Inc.
$32
Currax Pharmaceuticals LLC
$31
Horizon Therapeutics plc
$31
Alnylam Pharmaceuticals Inc.
$27
Valeritas, Inc.
$21
Supernus Pharmaceuticals, Inc.
$21
Chiesi USA, Inc.
$19
Lucid Diagnostics Inc.
$17
Ultragenyx Pharmaceutical Inc.
$17
DEXCOM, INC.
$14
Relypsa, Inc.
$13
Janssen Scientific Affairs, LLC
$13
Top 3 companies account for 69.2% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BAQSIMI · CONTRAVE · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ENTRESTO · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FLOWTRIEVER CATHETER · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · INVOKANA · InPen · Inpefa · JANUMET · JANUVIA · JARDIANCE · JUXTAPID · Kerendia · Korlym · LEQVIO · LYUMJEV · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · MYALEPT · MYCAPSSA · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NEXLIZET · ONPATTRO · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnia · Omnipod · OneTouch · OneTouch Verio Reflect · Ozempic · PRALUENT · Prolia · RECORLEV · RYBELSUS · Repatha · Rybelsus · S · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · SOTAGLIFLOZIN · STEGLATRO · STRENSIQ · SYNTHROID · Saxenda · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TROKENDI XR · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · VERQUVO · Vascepa · Veltassa · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZEPBOUND · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
51
County median income
$84,198
Nearest hospital to ZIP centroid (approximate)
SOUTHCOAST HOSPITALS GROUP
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Yacoub is a mixed practice specialist, with above-average Medicare volume (top 5% in MA), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Yacoub experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Yacoub performed 878 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Yacoub receive payments from pharmaceutical companies?
Yes. Dr. Yacoub received a total of $741,340 from 59 companies across 1,412 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yacoub's costs compare to other endocrinologists in Fall River?
Dr. Yacoub's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yacoub) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Fall River
Browse endocrinologists in Fall River ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in MA
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in MA
Which MA endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Corcept Therapeutics Payments to Doctors
See all physicians who received payments from Corcept Therapeutics.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology